What are the differences between ulcerative blepharitis and squamous blepharitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ulcerative vs. Squamous Blepharitis: Key Differences

Ulcerative blepharitis represents a severe form of staphylococcal anterior blepharitis with actual ulceration and tissue destruction at the eyelid margin, while squamous blepharitis is characterized by scaling and crusting without ulceration.

Clinical Presentation

Ulcerative Blepharitis

  • Tissue destruction: Actual ulcers and erosions develop at the eyelid margin 1
  • Severe inflammation: Represents acute exacerbations of chronic staphylococcal blepharitis 1
  • Eyelash involvement: Loss of eyelashes (madarosis) commonly occurs 1
  • Corneal complications: Higher risk of punctate epithelial erosions, marginal infiltrates, peripheral corneal defects, and corneal neovascularization 1
  • Associated organisms: In atopic patients, Candida species may play a causative role (found in 90% of ulcerative cases in one study) 2
  • Follicular involvement: Heavy involvement of the lash follicles 2

Squamous Blepharitis

  • Scaling without ulceration: Characterized by greasy or dry scaling, crusting, and erythema of the eyelid margin 1
  • Collarette formation: Distinctive cylindrical scales at the base of the eyelashes 1
  • Milder presentation: Generally less severe than ulcerative form 3
  • Two subtypes exist:
    • Staphylococcal: Hard, brittle scales with collarettes
    • Seborrheic: Greasy, oily scales often associated with seborrheic dermatitis of scalp and eyebrows 1

Pathophysiology

The key distinction is that ulcerative blepharitis involves actual tissue breakdown and ulcer formation, representing a more severe inflammatory response. Squamous blepharitis involves surface changes (scaling and crusting) without deeper tissue destruction 3. Both can be caused by staphylococcal organisms, but ulcerative blepharitis represents a more aggressive disease process with acute exacerbations 1.

Clinical Significance

Ulcerative blepharitis requires more aggressive treatment due to:

  • Higher risk of permanent structural damage
  • Greater potential for vision loss from corneal involvement 1
  • Need to consider fungal causes (especially Candida in atopic patients) 2
  • More likely to cause eyelash loss and lid margin scarring

Diagnostic Approach

For ulcerative blepharitis:

  • Look for actual erosions/ulcers (can be highlighted with fluorescein staining) 4
  • Perform repeated scrapings and cultures, especially in recalcitrant cases 2
  • Consider fungal cultures in atopic patients 2
  • Assess for herpes simplex (can cause erosive-ulcerative blepharitis) 4

For squamous blepharitis:

  • Identify scaling pattern (greasy vs. dry/brittle) 3
  • Look for collarettes at lash base 1
  • Check for associated seborrheic dermatitis 1

Treatment Implications

Ulcerative blepharitis may require:

  • More intensive antibiotic therapy (topical and potentially systemic)
  • Antifungal treatment if Candida is identified 2
  • Closer monitoring for corneal complications
  • Longer treatment duration

Squamous blepharitis typically responds to:

  • Standard lid hygiene measures
  • Topical antibiotics
  • Treatment of underlying seborrheic dermatitis if present 1

References

Guideline

blepharitis preferred practice pattern®.

Ophthalmology, 2024

Research

[Staphylococcus-associated blepharokeratoconjunctivitis. Clinical findings, pathogenesis and therapy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1997

Research

Erosive-ulcerative herpes simplex blepharitis.

Archives of ophthalmology (Chicago, Ill. : 1960), 1980

Related Questions

What is the recommended first-line antibiotic for anterior blepharitis?
What is the recommended treatment for angular blepharitis?
Is Augmentin (amoxicillin-clavulanate) effective for treating blepharitis?
What is the likely diagnosis and treatment for an elderly patient with eye drainage, crusting, and itching eyelids without pus?
What is the appropriate work‑up and conservative management for a 28‑year‑old male with a localized pearly lesion at the meibomian gland’s coronal line, mild erythema, no open skin disruption, no plaque, and normal lid retraction?
In a patient with COPD and frequent exacerbations, how should peripheral blood eosinophil count influence the decision to initiate long‑term azithromycin therapy?
What bottle volumes are available for 100,000 U/mL nystatin oral suspension?
What tube sizes are available for Nystatin cream?
What is the likely cause and recommended management for a patient with leukocytosis (WBC 12.4 ×10³/µL), anemia (hemoglobin 8.7 g/dL, hematocrit 25.8 %), thrombocytosis (platelets 599 ×10³/µL), neutrophil predominance (66 %) and lymphocyte 17 %?
What is the evidence comparing azithromycin 250 mg daily versus azithromycin 250 mg three times per week for long‑term prophylaxis in a COPD patient with frequent exacerbations who meets criteria for macrolide therapy?
What is the likely cause and recommended evaluation and management for a patient with low estradiol, normal follicle‑stimulating hormone (FSH), and amenorrhea?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.